Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2022 07:00 ET | Source: Indaptus Therapeutics

Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer

Seasoned Drug Developer Brings More Than Twenty Years of Medical Leadership and Clinical Oncology Experience On Track to Initiate Phase 1 Study of Decoy20 in 2022 NEW YORK, Jan. 03, 2022 (GLOBE...
December 01, 2021 08:00 ET | Source: Indaptus Therapeutics

Indaptus Therapeutics Appoints Mark Gilbert, M.D., to Board of Directors

NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announces the appointment of Mark Gilbert, M.D., to its Board of...
November 15, 2021 07:00 ET | Source: Indaptus Therapeutics

Indaptus Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announces financial results for the third quarter ended September 30, 2021...
September 15, 2021 07:00 ET | Source: Indaptus Therapeutics

Indaptus Therapeutics Receives Notice of Allowance for Strategic Patent

NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that the United States Patent and Trademark Office has issued a...